Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 19, 2014

Drug Name	Review Type	Class	Manufacturer
Sovaldi	New Drug Initial Review	Hepatitis C	Gilead
Otrexup	New Drug Initial Review	DMARD	Antares
Brintellix	New Drug Initial Review	Antidepressant	Takeda
Olysio	New Drug Initial Review	Hepatitis C	Johnson & Johnson
Natroba	New Drug Appeal	Head Lice	ParaPro
Quillivant XR	New Drug Appeal	Stimulant/ADHD	Pfizer
Linzess	New Drug Appeal	Guanylate Cyclase-C Agonist	Forest
TOBI Podhaler	New Drug Appeal	Aminoglycoside	Novartis
Abilify Maintena	PDL Appeal	Atypical Antipsychotic	Otsuka
Onglyza	PDL Appeal	DPP-4 Inhibitor	AstraZeneca